Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats

Hypertension

Volumn 46, Issue 4, 2005, Pages 745-750

  Debrah, Dan O ^a   Conrad, Kirk P ^b   Jeyabalan, Arundhathi ^b   Danielson, Lee A ^c   Shroff, Sanjeev G ^a  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Arterial compliance; Cardiac output; Hormones; Hypertension, arterial; Rats, spontaneously hypertensive; Vascular resistance; Vasodilation

Indexed keywords

ANGIOTENSIN II; RECOMBINANT RELAXIN; RELAXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ARTERIES; CARDIAC OUTPUT; COMPLIANCE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; INFUSION PUMPS; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, INBRED SHR; RATS, LONG-EVANS; RECOMBINANT PROTEINS; RELAXIN; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 31944449600     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000184230.52059.33     Document Type: Article

References (29)

1. Sherwood O. Relaxin's physiological roles and other diverse actions. Endocrinol Rev. 2004;25:205-234.
2. Conrad KP, Novak J. The emerging role of relaxin in renal and cardiovascular function. Am J Physiol. 2004;287:R250-R261.
3. Conrad KP, Debrah DO, Novak J, Danielson LA, Shroff SG. Relaxin modifies systemic arterial resistance and compliance in conscious, non-pregnant rats. Endocrinology. 2004;145:3289-3296.
4. Debrah DO, Conrad KP, Danielson LA, Shroff SG. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response. J Appl Physiol. 2004;98:1013-1020.
5. St-Louis J, Massicotte G. Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. Life Sci. 1985;37:1351-1357.
6. Massicote G, Parent A and St-Louis. Blunted response to vasoconstrictors in mesenteric vasculature but not in portal vein of spontaneously hypertensive rats treated with relaxin. Proc Soc Exp Biol Med. 1989;190:254-259.
7. Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest. 1999;103:525-533.
8. Samuel CS, Unemori EN, Mookerjee S, Bathgate RAD, Layfield SL, Mak J, Tregear GW, Du XJ. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology. 2004;145:4125-4133.
9. Danielson LA, Conrad KP. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. J Appl Physiol. 2003;95:1509-1514.
10. Novak J, Danielson LA, Kerchner LJ, Sherwood OD, Ramirez RJ, Moalli PA, Conrad KP. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest. 2001;107:1469-1475.
11. Fisher C, MacLean M, Morecroft I, Seed A, Johnston F, Hillier C, McMurray J. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation. 2002;106:292-295.
12. Parry LJ, Wilson BC, Poterski RS, Summerlee AJ. The cardiovascular effects of porcine relaxin in Brattleboro rats. Endocrine. 1998;8:317-322.
13. Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented rats. J Clin Invest. 1995;96:482-490.
14. Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. J Clin Invest. 1986;77:236-245.
15. Novak J, Reckelhoff J, Bumgarner L, Cockrell K, Kassab S, Granger JP. Reduced Sensitivity of the renal circulation to angiotensin II in pregnant rats. Hypertension. 1997;30:580-584.
16. 1 receptor antagonism in conscious normotensive but not hypertensive rats. Am J Physiol Heart Circ Physiol. 2005;288:H2289-H2297.
17. 1 receptor antagonist in hypertensive rats. Hypertension. 1999;34:1112-1116.
18. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 2000;8:361-370.
19. McLaughlin MK and Roberts JM. Hemodynamic changes. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Stamford, CT: Appletom & Lange; 1999:69-102.
20. Gilson GJ, Mosher MD, Conrad KP. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am J Physiol Heart Circ Physiol. 1992;263:H1911-H1918.
21. Slangen BFM, Out ICM, Verkeste CM, Peeters LLH. Hemodynamic changes in pregnancy in chronically instrumented, conscious rats. Am J Physiol. 1996;270:H1779-H1784.
22. Kakouris H, Eddie L, Summers R. Cardiac effects of relaxin in rats. Lancet. 1992;339:1076-1078.
23. Coulson CC, Thorp JM Jr, Mayer DC, Cefalo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol. 1996;87:610-612.
24. Kompa AR, Samuel CS, Summer RJ. Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin. Br J Pharmacol. 2002;137:710-718.
25. Masini E, Bani D, Bello MG, Bigazzi M, Mannaioni PF, Sacchi TB. Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide. Endocrinology. 1997;138:4713-4720.
26. Edouard DA, Pannier BM, London GM, Cuche JL, Safar ME Venous and arterial behavior during normal pregnancy. Am J Phyiol. 1998;274:H605-H612.
27. Seyde WC, Durieux ME, Longnecker DE. The hemodynamic response to isoflurane is altered in genetically hypertensive (SHR), as compared to normotensive (WKY) rats. Anesthesiology. 1987;66:798-804.
28. Cole DJ, Marcantonio S, Drummond JC. Anesthetic requirement of isoflurane is reduced in spontaneously hypertensive and Wistar-Kyoto rats. Lab Anim Sci. 1990;40:506-509.
29. Hibbard JU, Korcarz CE, Girardet Nendaz G, Lindheimer MD, Lang RM, Shroff SG. The arterial system in pre-eclampsia and chronic hypertension with superimposed preeclampsia. Br J Obstet Gynaecol. 2005;112:1-7.